Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02124421
Title Outcomes in CRS/HIPEC as Initial Treatment of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Acronym CRS/HIPEC
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mercy Medical Center
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.